October 28, 2014
Mylan is recalling about 16,000 bottles of the blood pressure drug metoprolol succinate extended release (Toprol XL). The reason for the recall of the 50 mg tablets is product mix-up, according to FDANews. The company received a report that a different size of a tablet with different markings was found in a bottle.
No adverse events were reported.
In June, Mylan recalled the antibiotic clarithromycin because of possible impurities, Reuters reported.
Wockhart recalled more than 11,000 bottles of the same drug at the end of the summer due to the product failing a dissolution test. In the spring, the company recalled more than 100,000 bottles of the drug for the same reason.
1. Mylan Becomes Latest Drugmaker to Recall Generic Blood Pressure Product. FDANews. 2014 Oct 24.
2. Palmer E. Mylan's recall of metoprolol succinate tablets is for a different cause than Wockhardt's and Dr. Reddy's. FiercePharma Manufacturing. 2014 Oct 21.
3. Reuters. Mylan recalls batches of Indian-made antibiotic. Pharmacy Learning Network. 2014 Jun 18.
4. Vaccaro S. Wockhart recalls BP drug. Pharmacy Learning Network. 2014 Sep 2.